A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT05896527 · COMPLETED
Trial details
- NCT number
- NCT05896527
- Sponsor
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-02
- Primary completion
- 2024-03-25
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.